{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T04:32:47Z","timestamp":1794717167229,"version":"4.9.1"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T00:00:00Z","timestamp":1739836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T00:00:00Z","timestamp":1739836800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-025-10574-6","type":"journal-article","created":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T21:06:19Z","timestamp":1739912779000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Elevated thrombosis-related biomarkers as predictors of disease severity and mortality in patients with severe fever with thrombocytopenia syndrome"],"prefix":"10.1186","volume":"25","author":[{"given":"Ting","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanyan","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuejing","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,18]]},"reference":[{"key":"10574_CR1","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.ijid.2017.02.017","volume":"58","author":"JW Liu","year":"2017","unstructured":"Liu JW, Wang L, Feng ZL, Geng DY, Sun Y, Yuan GY. Dynamic changes of laboratory parameters and peripheral blood lymphocyte subsets in severe fever with thrombocytopenia syndrome patients. Int J Infect Dis. 2017;58:45\u201351.","journal-title":"Int J Infect Dis"},{"issue":"8","key":"10574_CR2","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1007\/s11427-013-4518-9","volume":"56","author":"XS Zhang","year":"2013","unstructured":"Zhang XS, Liu Y, Zhao L, Li B, Yu H, Wen HL, et al. An emerging hemorrhagic fever in China caused by a novel bunyavirus SFTSV. Sci China Life Sci. 2013;56(8):697\u2013700.","journal-title":"Sci China Life Sci"},{"issue":"2","key":"10574_CR3","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1093\/cid\/cir776","volume":"54","author":"ZT Gai","year":"2012","unstructured":"Gai ZT, Liang MF, Zhang Y, Zhang S, Jin C, Wang SW, et al. Person-to-person transmission of severe fever with thrombocytopenia syndrome bunyavirus through blood contact. Clin Infect Dis. 2012;54(2):249\u201352.","journal-title":"Clin Infect Dis"},{"issue":"7","key":"10574_CR4","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1093\/infdis\/jis472","volume":"206","author":"ZT Gai","year":"2012","unstructured":"Gai ZT, Zhang Y, Liang MF, Jin C, Zhang S, Zhu CB, et al. Clinical progress and risk factors for death in severe fever with throm bocytopenia syndrome patients. J Infect Dis. 2012;206(7):1095\u2013102.","journal-title":"J Infect Dis"},{"issue":"7","key":"10574_CR5","first-page":"793","volume":"61","author":"L Xu","year":"2022","unstructured":"Xu L, Wang H, Liang BY, Wang T, Zheng X, Peng C. Clinical features and significance of coagulation dysfunction in severe fever with thrombocytopenia syndrome. Chin J Intern Med. 2022;61(7):793\u20136.","journal-title":"Chin J Intern Med"},{"issue":"12","key":"10574_CR6","first-page":"711","volume":"40","author":"J Li","year":"2022","unstructured":"Li J, Wang GQ, et al. Chinese Society of Infectious Diseases, Chinese Medical Association. Consensus on the diagnosis and treatment of severe fever with thrombocytopenia syndrome. Chin J Infect. 2022;40(12):711\u201321.","journal-title":"Chin J Infect"},{"issue":"12","key":"10574_CR7","doi-asserted-by":"publisher","first-page":"e0010967","DOI":"10.1371\/journal.pntd.0010967","volume":"16","author":"ZS Liu","year":"2022","unstructured":"Liu ZS, Zhang RL, Liu YN, Ma RZ, Zhang LG, Zhao Z, et al. Eosinophils and basophils in severe fever with thrombocytopenia syndrome patients: risk factors for predicting the prognosis on admission. PLoS Negl Trop Dis. 2022;16(12):e0010967\u201384.","journal-title":"PLoS Negl Trop Dis"},{"key":"10574_CR8","doi-asserted-by":"publisher","first-page":"803660","DOI":"10.3389\/fpubh.2021.803660","volume":"9","author":"MY Tao","year":"2022","unstructured":"Tao MY, Liu Y, Ling F, Chen YJ, Zhang R, Ren JP, et al. Severe fever with Thrombocytopenia Syndrome in Southeastern China, 2011\u20132019. Front Public Health. 2022;9:803660.","journal-title":"Front Public Health"},{"issue":"5","key":"10574_CR9","doi-asserted-by":"publisher","first-page":"e2820","DOI":"10.1371\/journal.pntd.0002820","volume":"8","author":"K Liu","year":"2014","unstructured":"Liu K, Cui N, Fang LQ, Wang BJ, Lu QB, Peng W, et al. Epidemiologic features and environmental risk factors of severe fever with thrombocytopenia syndrome, Xinyang, China. PLoS Negl Trop Dis. 2014;8(5):e2820.","journal-title":"PLoS Negl Trop Dis"},{"issue":"23","key":"10574_CR10","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.21037\/atm-22-5221","volume":"10","author":"LL Wang","year":"2022","unstructured":"Wang LL, Zhong JM, Xiao D, Huang W, Zheng Z, Jiang YM. Thrombomodulin (TM), thrombin-antithrombin complex (TAT), plasmin-\u03b12-plasmininhibitor complex (PIC), and tissue plasminogen activator-inhibitor complex (t-PAIC) assessment of fibrinolytic activity in postpartum hemorrhage: a retrospective comparative cohort study. Ann Transl Med. 2022;10(23):1273.","journal-title":"Ann Transl Med"},{"issue":"2","key":"10574_CR11","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1182\/blood-2017-12-768994","volume":"132","author":"H Loghmani","year":"2018","unstructured":"Loghmani H, Conway EM. Exploring traditional and nontraditional roles for thrombomodulin. Blood. 2018;132(2):148\u201358.","journal-title":"Blood"},{"issue":"6","key":"10574_CR12","first-page":"1033","volume":"55","author":"LR Hong","year":"2023","unstructured":"Hong LR, Chen YJ, Jiang QL, Jia RL, Li C, Feng LH. Predictive value of four items of new thrombus markers combined with conventional coagulation tests for thrombosis in antiphospholipid syndrome. J Peking Univ(Healt Sci). 2023;55(6):1033\u20138.","journal-title":"J Peking Univ(Healt Sci)"},{"issue":"6","key":"10574_CR13","doi-asserted-by":"publisher","first-page":"433","DOI":"10.5455\/medarh.2023.77.433-439","volume":"77","author":"VT Nguyen","year":"2023","unstructured":"Nguyen VT, Nguyen-Phan HN, Hoang BB. Serum Thrombomodulin Level can predict mortality in patients with Sepsis? Med Arch. 2023;77(6):433\u20139.","journal-title":"Med Arch"},{"key":"10574_CR14","doi-asserted-by":"crossref","unstructured":"Lundbech M, Krag AE, Christensen TD, Hvas AM. Corrigendum to Thrombin generation, thrombin-antithrombin complex, and prothrombin fragment F1\u2009+\u20092 as biomarkers for hypercoagulability in cancer patients [Thromb. Res. 186. 2020. 80\u201385]. Thromb Res. 2022;216:130\u2013132.","DOI":"10.1016\/j.thromres.2021.11.017"},{"issue":"1","key":"10574_CR15","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1186\/s12885-022-10106-4","volume":"22","author":"K Asanuma","year":"2022","unstructured":"Asanuma K, Nakamura T, Okamoto T, Hagi T, Kita K, Nakamura K, et al. Do coagulation or fibrinolysis reflect the disease condition in patients with soft tissue sarcoma? BMC Cancer. 2022;22(1):1075.","journal-title":"BMC Cancer"},{"issue":"4","key":"10574_CR16","first-page":"1065","volume":"67","author":"XQ Guo","year":"2021","unstructured":"Guo XQ, Tao HY, Li D, Li Y. The \u03b12-Plasmin inhibitor-plasmin complex is a potential biomarker of venous thromboembolism in Orthopedic Trauma patients. Clin Lab. 2021;67(4):1065.","journal-title":"Clin Lab"},{"issue":"3","key":"10574_CR17","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.thromres.2004.12.007","volume":"116","author":"A Nordenhem","year":"2005","unstructured":"Nordenhem A, Leander K, Hallqvist J, de Faire U, Sten-Linder M, Wiman B. The complex between tPA and PAI-1: risk factor for myocardial infarction as studied in the SHEEP project. Thromb Res. 2005;116(3):223\u201332.","journal-title":"Thromb Res"},{"issue":"5","key":"10574_CR18","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1007\/s00380-012-0287-9","volume":"28","author":"B Er\u017een","year":"2013","unstructured":"Er\u017een B, \u0160abovi\u010d M. In young post-myocardial infarction male patients elevated plasminogen activator inhibitor-1 correlates with insulin resistance and endothelial dysfunction. Heart Vessels. 2013;28(5):570\u20137.","journal-title":"Heart Vessels"},{"issue":"3","key":"10574_CR19","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1160\/TH16-08-0600","volume":"117","author":"MP Winter","year":"2017","unstructured":"Winter MP, Kleber ME, Koller L, Sulzgruber P, Scharnagl H, Delgado G, et al. Prognostic significance of tPA\/PAI-1 complex in patients with heart failure and preserved ejection fraction. Thromb Haemost. 2017;117(3):471\u20138.","journal-title":"Thromb Haemost"},{"key":"10574_CR20","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.thromres.2018.11.010","volume":"173","author":"H Mei","year":"2019","unstructured":"Mei H, Jiang Y, Luo LL, Huang RB, Su L, Hou M, et al. Evaluation the combined diagnostic value of TAT, PIC, tPAIC, and sTM in disseminated intravascular coagulation: a multi-center prospective observational study. Thromb Res. 2019;173:20\u20136.","journal-title":"Thromb Res"},{"key":"10574_CR21","unstructured":"Zong L, Yang F, Si L, Zheng MJ, Xu YH. Abnormal coagulation activity and the related clinical significance in patients with novel bunyavirus infection. Chin J Lab Med. 2022; (1):65\u201370."},{"key":"10574_CR22","doi-asserted-by":"publisher","first-page":"1335664","DOI":"10.3389\/fmicb.2024.1335664","volume":"15","author":"YY Xia","year":"2024","unstructured":"Xia YY, Jia B, Chen YX, Wang S, Xu XJ. Clinical value of coagulation parameters in predicting the severity of severe fever with thrombocytopenia syndrome. Front Microbiol. 2024;15:1335664.","journal-title":"Front Microbiol"},{"key":"10574_CR23","doi-asserted-by":"publisher","first-page":"1239420","DOI":"10.3389\/fmicb.2023.1239420","volume":"14","author":"TH Huang","year":"2023","unstructured":"Huang TH, Fan YY, Xia YY, Xu XJ, Chen XY, Ye HL, et al. Association of low HDL-c levels with severe symptoms and poor clinical prognosis in patients with severe fever and thrombocytopenia syndrome. Front Microbiol. 2023;14:1239420.","journal-title":"Front Microbiol"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-10574-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-025-10574-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-10574-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T08:50:56Z","timestamp":1739955056000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-025-10574-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,18]]},"references-count":23,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["10574"],"URL":"https:\/\/doi.org\/10.1186\/s12879-025-10574-6","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,18]]},"assertion":[{"value":"28 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by the Affiliated Drum Tower Hospital of Nanjing University Medical School (Ethics code: 2022-238-02). All patients signed written informed consent. The study was performed in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki. Clinical trial number: not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"235"}}